This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $2,234.41, is for the supply of 4,566,795,517 units of 15 mg Armour Thyroid tablets. The contract has an ultimate completion date of December 27, 2024 and was awarded on December 26, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to military healthcare facilities and veterans' medical centers. The company holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the DLA to issue firm fixed-price delivery orders for pharmaceutical products to support the medical supply needs of the Department of Defense.
Generated 3/27/25, 10:05 AM